Published Date: 13 Mar 2023
The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.
Read Full NewsA 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, nontattooed skin and bilateral hilar nodes.
The AVANT GUARD trial design stacked the odds in favor of PFA over antiarrhythmic drugs. Yet, the results are unconvincing to this electrophysiologist. Maybe not all PFA systems are created equal.
Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.
Dr Anne Peters discusses the varying subtypes of diabetes.
Cardiologists Bob Harrington and Lisa Rosenbaum discuss the loss of trust in medicine, how it may reflect patients’ desire for agency, and strategies to earn it back.
A 20-year-old man on daily finasteride suffers an ischemic stroke with multifocal carotid stenoses and multiple prothrombotic genetic variants — could the drug be implicated?
Medical specialties in which most doctors think they have either a promising or grim near-term (next 3 years) future are revealed.
1.
Why preventive mastectomy isn't offered to everyone at risk
2.
A protein with new anticancer activity has been identified
3.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
4.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
5.
Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.
1.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
4.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
5.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Navigating the Complexities of Ph Negative ALL - Part XI
3.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation